Work

Expert consensus on perioperative inflammation management in cardiac surgery involving cardiopulmonary bypass

Year: 2025
Type: article
Abstract: Background: The perioperative inflammatory response is a common pathophysiological phenomenon in cardiac and vascular surgeries. Systemic inflammatory response syndrome (SIRS) frequently occurs following cardiopulmonary bypass (CPB) surgery, with an incidence of 20% to 58.7%. Perioperative SIRS and multi-organ dysfunction syndrome (MODS) are major contributors to poor patient outcomes and mortality. However, a standardized framework for diagnosing and managing perioperative inflammation during CPB is currently lacking. Therefore, this consensus aimed to establish standardized, evidence-based recommendations for managing perioperative inflammation in cardiac surgeries involving CPB to improve patient outcomes and reduce mortality. Methods: A systematic literature review was conducted using databases such as PubMed, Embase, CNKI, and Wanfang. Search terms included “Cardiac Surgery”, “Inflammation”, and “Cardiopulmonary Bypass”, among others. Literature screening involved duplicate removal, dual independent reviewing (title/abstract review, and full-text assessment), yielding 102 eligible studies (exclusion criteria: irrelevance, incomplete data, case series, or small sample size trials n≤10). Data extraction followed standardized protocols with dual-reviewer verification and third-reviewer arbitration. A 23-expert multidisciplinary panel (cardiac surgery, anesthesiology, intensive care, perfusion) employed a modified Delphi process, with recommendations requiring ≥80% agreement (A/B on 5-point scale) from ≥70% participating panelists across two consensus rounds. Unresolved items underwent evidence-based arbitration. Evidence was graded using GRADE (quality: high to very low; strength: strong/conditional), ensuring rigorous, clinically actionable recommendations. Results: The consensus recommendations emphasize strategies to minimize perioperative inflammation in critically ill patients. ERAS protocols, goal-directed perfusion, and controlled perioperative blood transfusions are crucial for reducing surgical trauma and inflammation. Temperature management during CPB and lung-protective ventilation strategies are recommended to prevent inflammatory responses. Additionally, miniaturized CPB systems, ultrafiltration (UF), and biocompatible coating materials reduce blood contact with foreign surfaces, further mitigating inflammation. The use of serine protease inhibitors and appropriate blood glucose control are also beneficial. Early goal-directed analgesia and sedation, alongside the distinction between infectious and non-infectious inflammatory causes, are critical for optimal outcomes. Conclusions: The consensus introduces novel approaches, including personalized glycemic control for diabetic and non-diabetic patients, and advanced CPB techniques such as miniaturized systems, biocompatible coatings, and UF. It also highlights innovative pharmacological agents like alpha-2 adrenergic receptor agonists and serine protease inhibitors, providing a comprehensive, evidence-based framework for improving perioperative inflammation management in CPB-related surgeries. This consensus serves as a critical step toward standardizing care in CPB-related cardiac surgeries, ultimately benefiting patient recovery and quality of life.
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: diamond
OpenAlex ID: W4411105102
FWCI: 2.276
Cites:
Cited by: 4
Related to: 10